Aflibercept biosimilar (PanGen Biotech)

N/A

Report date: 2025/08/01 14:25:39

Base Information

Drug NameAflibercept biosimilar (PanGen Biotech)
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Recombinant protein > Fusion protein > Fc fusion proteinBiologics > Biosimilar
Mechanisms of ActionVascular endothelial growth factor A inhibitorsPlacental Growth Factor inhibitors
TargetsVascular endothelial growth factor APlacental Growth Factor
Therapy Area/IndicationsMacular Degeneration
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesPangen Biotech
China Registration ClassN/A

Develop Information

Active CompaniesPangen Biotech
Inactive CompaniesN/A
Active IndicationsMacular Degeneration
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A